AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy offers hope for Hard-to-Treat blood disorder
Disease control CompletedThis early-phase study tested a new cell therapy called YTS109 in 7 people with autoimmune hemolytic anemia (AIHA) whose disease did not respond to at least three prior treatments. The therapy uses specially engineered immune cells to target and destroy the faulty cells causing t…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Scientists investigate immune system role in rare blood disorder
Knowledge-focused CompletedThis study looked at the immune cells (T cells) of people with autoimmune hemolytic anemia, a condition where the body attacks its own red blood cells. Researchers compared 27 patients to healthy volunteers to understand how T cells behave and how treatments like steroids affect …
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated May 17, 2026 10:26 UTC
-
New registry aims to unlock secrets of rare blood disorders in youth
Knowledge-focused CompletedThis study created a registry for children and young adults with severe immune cytopenias—conditions where the immune system attacks blood cells. Researchers observed 80 participants over up to 4 years, collecting data on symptoms, treatments, and lab results. The goal was to imp…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC